Dr. Rath Health Foundation

Dr. Rath Health Foundation

Responsibility for a healthy world Dr. Rath Research Institute 100+ Studies Published In PubMed

News & Comment – October 2015

All news stories and comments were first published in our newsletter. If you would like to receive the newsletter regularly, please send us an email.

Dangerous ‘Pharma Cartels’ Trafficking Painkillers


Federal authorities say a large number of traditional drug cartels in Mexico are now dealing in pharmaceutical drug trafficking, honing in on the lucrative business of selling highly addictive painkillers across the border. According to U.S. Attorney Laura E. Duffy, federal investigators discovered elaborate Pharma-Cartels have operated numerous websites selling pills to thousands of clients who paid hundreds of thousands of dollars a month for highly addictive painkillers.


In the world of the ‘business with disease’, the key driving forces are profit and the accumulation of wealth. It isn’t important to drug makers how these profits are generated, or through whom, simply that they are.

To learn more about the main principles governing the Pharma Cartel, read The Laws of the Pharmaceutical Industry – and then share this information as widely as possible!

Permalink 22 October 2015

Read article on the nbcsandiego.com website (USA)

I didn’t think TTIP could get any scarier, but then I spoke to the EU official in charge of it


With just eight words she exposed everything that's wrong with the deal, and why it needs to be defeated.


Along with her colleagues in the so-called European Commission, Trade Commissioner Cecilia Malmström was appointed to her post by the Commission’s unelected President, Jean-Claude Juncker.

Hardly surprisingly, therefore, having assumed her post through never having to stand in a proper democratic election, Malmström coldly insists she does not take her mandate from the European people. As such, with the dangerous TTIP trade deal being negotiated in a highly secretive fashion behind closed doors, it quite rightly continues to be strongly opposed by European and American people alike.

Further information on TTIP (also known as TAFTA) can be found here.

Image by Security and Defence Agenda (originally posted to Flickr as sda - 0044) [CC BY 2.0], via Wikimedia Commons

Permalink 21 October 2015

Read article in the Independent (UK)

Selenium may help fight pre-cancer cervical condition


Long-term consumption of selenium supplements may help reverse the progression of the ‘pre-cancer’ condition cervical intraepithelial neoplasia grade 1 (CIN1), say researchers in Iran.


Although treatable in its early stages, once cervical cancer has metastasized patient outcome is poor. Significantly, therefore, research conducted at the Dr. Rath Research Institute in California has shown that critical steps in its development and spread can be inhibited through the use of a specific combination of micronutrients that includes vitamin C, the amino acids lysine and proline, and an extract from green tea.

Permalink 19 October 2015

Read article at nutraingredients.com

Pfizer Raised Prices on 133 Drugs This Year, And It's Not Alone


A single, 5,000 percent price hike on an anti-parasitic drug made by Turing Pharmaceuticals garnered national media attention. But it’s just one of hundreds of smaller price increases drug companies make in the U.S. each year, a tactic the industry uses to generate more revenue from older medications.


Price rises such as these provide a good illustration of why we refer to the pharma industry as the “business with disease”. Through the ownership and control of synthetic chemicals portrayed as “medicines”, drug manufacturers can arbitrarily define their profits. Functioning as corporate stakeholders feeding a ruthless and cynical investment industry that is driven by shareholder value, profits, not the interests of patients, are the highest priority.

Image by Lauri Silvennoinen [CC BY-SA 3.0 or GFDL], via Wikimedia Commons

Permalink 12 October 2015

Read article at bloomberg.com

The use of bisphosphonate drugs is associated with an increased risk of atypical hip fractures


The use of bisphosphonates, a group of drugs used to prevent hip breakages in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint, understood as those that occur in less frequent locations.


Causing new diseases, and worsening the existing ones they are meant to be treating, is a key strategy of the business with disease as it results in doctors prescribing still further drugs and the pharma industry making even more money from the needless misery of patients.

Significantly, therefore, as a direct consequence of this, orthodox medicine has now become the third leading cause of death in the United States – surpassed only by deaths from heart disease and cancer.

Image: Image by Phalinn Ooi [CC BY 2.0], via flickr.com

Permalink 9 October 2015

Read article at medicalxpress.com

Statins: Heart disease drug speeds up ageing process, warns new research


Statins make regular users become older faster, leaving them open to long-term mental and physical decline, according to disturbing new research.


Speeding up the ageing process is merely the latest in a very long list of side-effects caused by statin drugs.

Other known problems include raising the risk of developing cataractsbreast cancermuscle pain and muscular injuriesserious kidney problemsosteoarthritis of the kneenerve damageeye damage, fatiguediabetes – and, ironically, even calcification of the arteries

To learn how high cholesterol levels can be eradicated naturally, without drugs, visit the Cellular Health section of our Foundation website.

Image: By The.Comedian [CC BY-NC 2.0], via flickr.com

Permalink 8 October 2015

Read article in the Daily Express (UK)

Austria and Italy Celebrate Bans on GM Crops with EU Opt-Out


Austrian Health Minister Sabine Oberhauser and a number of Italian Ministries have confirmed that both countries are officially requesting an opt-out from growing the eight varieties of GM maize permitted or set to be permitted at the EU level, thus there will now be a full ban on GM crops in both countries under new EU regulations.


In opting out of GMO cultivation in the Brussels EU, Austria and Italy thus join France, Germany, Northern Ireland, Scotland, Lithuania, Greece and Latvia, all of whom are similarly taking action to ban the cultivation of genetically modified crops.

Moreover, in the coming weeks, it is expected that Hungary, Luxembourg and Wales will formally announce their own prohibitions.

Image: By Susan Melkisethian [CC BY-NC-ND 2.0], via flickr.com

Permalink 7 October 2015

Read article at sustainablepulse.com

Daily dose of vitamin C can slash your risk of heart attacks


A daily dose of vitamin C could prevent strokes and heart attacks and provide protection against blindness and diabetes.


Slowly but surely, the message from the recent study published by our research institute – that an optimum intake of vitamin C is the key measure for preventing heart disease – is beginning to get through.

Building on a discovery made by Dr. Rath in the early 1990s, the widespread spreading of this knowledge will ultimately deal a major blow to the cholesterol theory of heart disease and the pharmaceutical industry’s associated $30 billion annual sales in patented statin drugs.

Image taken from the free bodyxq Heart app. Available for iOS and Android.

Permalink 6 October 2015

Read article in the Daily Express (UK)

U.N. Sets Goal to End Global Hunger by 2030


At this week’s general assembly, ending hunger was among more than a dozen goals to make the world a better place.


Don’t believe anyone who tells you that it isn’t possible to eradicate global hunger. In 2008, the UN’s own Food and Agriculture Organization estimated the cost of achieving it at only 30 billion dollars a year.

To put this figure into context, with global military expenditure in 2014 totalling 1.8 trillion dollars, the world now spends more money on its armed forces in one week than it would cost to end global hunger. Looking at this another way, 30 billion dollars equates to a mere 0.04% of gross world product(the total value of all goods and services produced on the planet in a single year).

As such, if enough of us draw attention to these facts and become active in seeking positive change, the goal of the Movement of Life to bring an end to malnutrition and world hunger can be achieved.

Image: By Augustus Binu (Own work) [GFDL or CC BY-SA 3.0], via Wikimedia Commons

Permalink 5 October 2015

Read article at takepart.com

Reputation matters: Why the rift between pharma and patients is ballooning


What’s in a reputation? A lot, according to PatientView. The group, headed up by Dr. Alex Wyke in the U.K., published a report, "The Corporate Reputation of Pharma – from a Patient Perspective," in which 76 patient groups assessed corporate reputation based on six key indicators, including: patient-centered strategy; high-quality information; ensuring patient safety; making useful, high-quality products; transparency; and integrity.


The patient groups surveyed for this report rated the corporate reputation of the drug industry as low, verging on abysmal. None of them ranked the industry as excellent.

The only industry ranked lower than the drug industry was the for-profit insurance industry. Significantly therefore, with a 2013 survey finding that 60% of respondents believe drug companies are more interested in treating cancer than curing it, it is clear patients are increasingly recognizing that there are serious and unsolvable conflicts of interest between the pharma cartel and public health.

Permalink 2 October 2015

Read article at biopharmadive.com

India mulls reclassifying vitamins as drugs if they come with health claims


India may classify vitamin supplements as drugs rather than foods if the manufacturers of such products claim they can treat or prevent disease.


With scientific evidence growing worldwide that vitamins and other micronutrients are the safest and most effective means of preventing and treating disease, the Indian regulatory authorities’ possible reclassification of non-patentable natural health approaches is clearly being considered as a means of protecting the trillion-dollar-a-year pharmaceutical investment business.

Permalink 1 October 2015

Read article at in-pharmatechnologist.com

Earlier comments can be found on the pages for September, August, July and June 2015.